Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
|
IT |
|
K
|
Kizilbuk Gayrimenkul Yatirim Ortakligi AS
IST:KZBGY.E
|
TR |
|
Qube Holdings Ltd
ASX:QUB
|
AU |
|
LINKBANCORP Inc
NASDAQ:LNKB
|
US |
|
Klondike Gold Corp
XTSX:KG
|
CA |
|
Helius Medical Technologies Inc
NASDAQ:HSDT
|
US |
|
S
|
Sentral REIT
KLSE:SENTRAL
|
MY |
|
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
|
BR |
|
Banco Macro SA
NYSE:BMA
|
AR |
Cash Flow Statement
Cash Flow Statement
Fine Foods & Pharmaceuticals NTM SpA
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Sep-2021 | Dec-2021 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
9
|
9
|
(3)
|
(1)
|
13
|
2
|
6
|
(1)
|
(1)
|
(10)
|
(10)
|
(7)
|
(5)
|
1
|
(4)
|
(4)
|
3
|
5
|
8
|
9
|
12
|
13
|
|
| Depreciation & Amortization |
8
|
8
|
9
|
10
|
12
|
12
|
16
|
13
|
14
|
15
|
15
|
19
|
16
|
16
|
17
|
17
|
17
|
17
|
16
|
16
|
16
|
16
|
|
| Change in Deffered Taxes |
0
|
0
|
1
|
1
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(5)
|
(5)
|
(5)
|
(5)
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
|
| Other Non-Cash Items |
3
|
1
|
11
|
9
|
1
|
16
|
14
|
12
|
5
|
13
|
15
|
16
|
14
|
9
|
8
|
9
|
4
|
4
|
6
|
5
|
6
|
8
|
|
| Cash Taxes Paid |
2
|
2
|
2
|
0
|
1
|
2
|
5
|
5
|
4
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
2
|
1
|
|
| Change in Working Capital |
(22)
|
(5)
|
0
|
(0)
|
6
|
(12)
|
(19)
|
(28)
|
(22)
|
(16)
|
(12)
|
(24)
|
(15)
|
(11)
|
(4)
|
5
|
14
|
14
|
14
|
10
|
(1)
|
(0)
|
|
| Cash from Operating Activities |
(3)
N/A
|
14
N/A
|
19
+36%
|
19
+2%
|
30
+57%
|
17
-43%
|
16
-5%
|
(6)
N/A
|
(5)
+8%
|
(1)
+85%
|
4
N/A
|
(0)
N/A
|
6
N/A
|
10
+79%
|
19
+88%
|
28
+53%
|
40
+41%
|
42
+5%
|
46
+10%
|
43
-6%
|
37
-14%
|
39
+5%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(90)
|
(26)
|
(20)
|
(18)
|
(16)
|
(14)
|
(17)
|
(16)
|
(20)
|
(20)
|
(16)
|
(21)
|
(17)
|
(17)
|
(19)
|
(20)
|
(22)
|
(30)
|
(35)
|
(40)
|
(42)
|
(39)
|
|
| Other Items |
0
|
(68)
|
(67)
|
4
|
3
|
(5)
|
(5)
|
(20)
|
(15)
|
(15)
|
1
|
(1)
|
53
|
53
|
65
|
67
|
12
|
12
|
3
|
3
|
3
|
3
|
|
| Cash from Investing Activities |
(90)
N/A
|
(93)
-4%
|
(87)
+7%
|
(15)
+83%
|
(12)
+17%
|
(19)
-55%
|
(22)
-13%
|
(36)
-68%
|
(34)
+6%
|
(34)
-1%
|
(15)
+55%
|
(22)
-44%
|
37
N/A
|
36
-2%
|
46
+29%
|
47
+3%
|
(10)
N/A
|
(18)
-71%
|
(32)
-78%
|
(37)
-19%
|
(38)
-2%
|
(36)
+6%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
39
|
(3)
|
(5)
|
(5)
|
(4)
|
(4)
|
(8)
|
(7)
|
(5)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(2)
|
|
| Net Issuance of Debt |
28
|
(15)
|
3
|
2
|
(11)
|
12
|
18
|
66
|
65
|
51
|
9
|
12
|
(11)
|
(16)
|
(53)
|
(61)
|
(60)
|
(53)
|
(11)
|
(9)
|
12
|
11
|
|
| Cash Paid for Dividends |
0
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
0
|
(2)
|
(2)
|
(2)
|
0
|
(3)
|
(3)
|
(3)
|
0
|
(3)
|
(3)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
67
N/A
|
(20)
N/A
|
(4)
+80%
|
(5)
-27%
|
(17)
-234%
|
5
N/A
|
7
+50%
|
56
+704%
|
56
-1%
|
46
-18%
|
5
-90%
|
7
+55%
|
(13)
N/A
|
(18)
-36%
|
(56)
-204%
|
(64)
-15%
|
(64)
+0%
|
(56)
+11%
|
(14)
+75%
|
(12)
+18%
|
8
N/A
|
5
-35%
|
|
| Change in Cash | |||||||||||||||||||||||
| Net Change in Cash |
(26)
N/A
|
(100)
-281%
|
(72)
+28%
|
(1)
+99%
|
1
N/A
|
3
+294%
|
2
-42%
|
14
+751%
|
16
+17%
|
11
-34%
|
(7)
N/A
|
(15)
-120%
|
29
N/A
|
27
-5%
|
9
-68%
|
12
+36%
|
(34)
N/A
|
(32)
+5%
|
0
N/A
|
(6)
N/A
|
7
N/A
|
8
+24%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(93)
N/A
|
(12)
+88%
|
(1)
+92%
|
1
N/A
|
15
+1 201%
|
3
-80%
|
(1)
N/A
|
(22)
-3 002%
|
(25)
-15%
|
(21)
+17%
|
(12)
+40%
|
(21)
-73%
|
(11)
+48%
|
(7)
+32%
|
(0)
+96%
|
9
N/A
|
18
+100%
|
12
-34%
|
11
-4%
|
3
-77%
|
(5)
N/A
|
0
N/A
|
|